Trial Profile

A safety and efficacy study of EB-02 for the treatment of internal hemorrhoids

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 18 Feb 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EB-02 (Primary)
Indications Haemorrhoids
Focus Adverse reactions; Proof of concept; Therapeutic Use
Sponsors Edesa Biotech

Most Recent Events

13 Feb 2020 According to an Edesa Biotech media release, the company plans to initiate this study later this year.
10 Sep 2019 New trial record
05 Sep 2019 According to an Edesa Biotech media release, if the initial results of the trial are positive the company plans to transition from a proof of concept study to a Phase 2 study.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com